Editorial
Copyright ©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Apr 14, 2009; 15(14): 1665-1672
Published online Apr 14, 2009. doi: 10.3748/wjg.15.1665
MicroRNA signatures in liver diseases
Xian-Ming Chen
Xian-Ming Chen, Department of Medical Microbiology and Immunology, Creighton University Medical Center, Criss II, Room 529, 2500 California Plaza, Omaha, NE 68178, United States
Author contributions: Chen XM wrote the paper.
Correspondence to: Xian-Ming Chen, MD, Associate Professor, Department of Medical Microbiology and Immunology, Creighton University Medical Center, Criss II, Room 529, 2500 California Plaza, Omaha, NE 68178, United States. xianmingchen@creighton.edu
Telephone: +1-402-2803750
Fax: +1-402-2801875
Received: February 6, 2009
Revised: March 3, 2009
Accepted: March 10, 2009
Published online: April 14, 2009
Abstract

MicroRNAs (miRNAs) are an emerging class of highly conserved non-coding small RNAs that regulate gene expression at the post-transcriptional level. It is now clear that miRNAs can potentially regulate every aspect of cellular activity, including differentiation and development, metabolism, proliferation, apoptotic cell death, viral infection and tumorigenesis. Recent studies provide clear evidence that miRNAs are abundant in the liver and modulate a diverse spectrum of liver functions. Deregulation of miRNA expression may be a key pathogenetic factor in many liver diseases including viral hepatitis, hepatocellular cancer and polycystic liver diseases. A clearer understanding of the mechanisms involved in miRNA deregulation will offer new diagnostic and therapeutic strategies to treat liver diseases. Moreover, better understanding of miRNA regulation and identification of tissue-specific miRNA targets employing transgenic/knockout models and/or modulating oligonucleotides will improve our knowledge of liver physiology and diseases.

Keywords: MicroRNAs, Non-coding RNAs, Liver, Tumorigenesis, Gene regulation